2,2-Diphenylacetyl chloride → N-(5-Cyclopropyl-[1,3,4]oxadiazol-2-yl)-2,2-diphenyl-acetamide
반응식
[C:1]1([CH:7]([C:11]2[CH:16]=[CH:15][CH:14]=[CH:13][CH:12]=2)[C:8](Cl)=[O:9])[CH:6]=[CH:5][CH:4]=[CH:3][CH:2]=1.[CH:17]1([C:20]2[O:24][C:23]([NH2:25])=[N:22][N:21]=2)[CH2:19][CH2:18]1>>[CH:17]1([C:20]2[O:24][C:23]([NH:25][C:8](=[O:9])[CH:7]([C:11]3[CH:16]=[CH:15][CH:14]=[CH:13][CH:12]=3)[C:1]3[CH:6]=[CH:5][CH:4]=[CH:3][CH:2]=3)=[N:22][N:21]=2)[CH2:19][CH2:18]1참가 물질
3
실험 절차
The title compound, white solid, m.p. 159-160° C. and MS: m/e=320.3 (M+H+) was prepared in accordance with the general method of example 44a from 2,2-diphenylacetic acid chloride and 5-cyclopropyl-[1,3,4]oxadiazol-2-ylamine.
출처 및 근거
- ORD 기록
- ord-709f5177ee374e428a871d21bb62977e
- 출처 데이터셋
- uspto-grants-2002_10
- 특허 번호
- US06462198B1
반응 노트
불러오는 중…